AGENTS AND METHODS FOR VISUALIZING ANALYTES
    1.
    发明申请
    AGENTS AND METHODS FOR VISUALIZING ANALYTES 有权
    用于可视化分析的代理和方法

    公开(公告)号:US20130323168A1

    公开(公告)日:2013-12-05

    申请号:US13885393

    申请日:2011-11-15

    IPC分类号: A61K51/04 G01N33/60 C07F9/70

    摘要: Provided herein are novel compounds based on xanthene, for example biarsenical compounds, which are useful as molecular probes. The compounds contain at least one isotope atom, such as a radioisotope atom. Methods for visualizing tetracysteine-tagged analyte molecules such as proteins using said compounds, methods for synthesizing said compounds, and methods for treating cancer or other hyperproliferative disorders using said compounds are also provided.

    摘要翻译: 本文提供了基于呫吨的新型化合物,例如可用作分子探针的双缩醛化合物。 该化合物含有至少一个同位素原子,例如放射性同位素原子。 还提供了使用所述化合物显现四羧酸标记的分析物分子如蛋白质的方法,用于合成所述化合物的方法,以及使用所述化合物治疗癌症或其它过度增殖性疾病的方法。

    ARG-GLY-ASP-CONJUGATED ALPHA-MELANOCYTE STIMULATING HORMONE HYBRID PEPTIDE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME
    2.
    发明申请
    ARG-GLY-ASP-CONJUGATED ALPHA-MELANOCYTE STIMULATING HORMONE HYBRID PEPTIDE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME 有权
    ARG-GLY-ASP-结合的阿尔法 - 梅毒素刺激性霍乱胶囊用于诊断和治疗MELANOMA,包括METASTATIC MELANOMA及其相关方法

    公开(公告)号:US20120107237A1

    公开(公告)日:2012-05-03

    申请号:US13321942

    申请日:2010-05-28

    摘要: The present invention is directed to novel non-invasive diagnostic and therapeutic tools/compounds comprising a hybride cyclic peptide which utilizes a cyclic peptide chelating group wherein the compound binds to a MSH receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers. The novel imaging probes are capable of detecting cancerous melanoma cells, as well as their metastatic spread in tissues. This represents a quantum step forward in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention will also be useful to initiate therapy for melanoma as well as monitor patients response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compound according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

    摘要翻译: 本发明涉及新颖的非侵入性诊断和治疗工具/化合物,其包含利用环肽螯合基团的杂环环肽,其中所述化合物结合MSH受体以成像和治疗癌症,特别是黑素瘤,包括转移性黑素瘤 体内。 本发明代表了目前依赖于组织活检以诊断这些癌症的本领域的明显进步。 新型成像探针能够检测癌细胞黑素瘤细胞,以及它们在组织中的转移扩散。 这代表了使用非侵入性分子成像技术在黑素瘤的诊断和治疗中包括转移性黑素瘤的量子进步。 本发明的新型探针也可用于启动黑素瘤的治疗以及监测患者对化疗治疗的反应和用于治疗黑素瘤/转移性黑色素瘤的其它干预或治疗。 根据本发明的化合物可以用作许多病症和疾病状态的诊断工具以及用于治疗这些病症和疾病状态的治疗剂。

    Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient
    4.
    发明授权
    Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient 有权
    螯合剂缀合的α-MSH肽衍生物,其制备方法和用于诊断和治疗黑素瘤的组合物,包括其作为活性成分

    公开(公告)号:US08124054B2

    公开(公告)日:2012-02-28

    申请号:US12409288

    申请日:2009-03-23

    IPC分类号: A61K51/00 A61M36/14

    摘要: Disclosed are chelating agent-conjugated α-MSH peptide derivatives, preparation methods thereof, and compositions for use in a diagnosis or treatment of a melanoma tumor containing the same as an active ingredient. The novel α-MSH peptide derivatives conjugated with chelating agent according to the present invention are highly selective to the melanocortin-1 receptor which is α-MSH receptor expressing in melanoma tumor and their labeling rate of a radioactive isotope is high. Also, they remain in kidney shortly and have high taking rate of the melanoma tumor. Therefore, with the aforesaid reasons, they may be effectively used for early diagnosis or treatment of melanoma tumor.

    摘要翻译: 公开了螯合剂缀合的α-MSH肽衍生物,其制备方法和用于诊断或治疗含有其作为活性成分的黑素瘤肿瘤的组合物。 与根据本发明的螯合剂缀合的新型α-MSH肽衍生物对黑素细胞-1受体具有高选择性,黑素皮质素-1受体是黑素瘤肿瘤中表达的α-MSH受体,并且其放射性同位素的标记率高。 此外,他们很快就保持在肾脏,并且具有高的黑色素瘤肿瘤的摄入率。 因此,由于上述原因,它们可以有效地用于黑色素瘤肿瘤的早期诊断或治疗。

    COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME

    公开(公告)号:US20190106474A1

    公开(公告)日:2019-04-11

    申请号:US16039858

    申请日:2018-07-19

    申请人: STC. UNM

    发明人: Yubin Miao Haixun Guo

    摘要: The present invention is directed to novel non-invasive diagnostic tools/compounds to image cancers, especially, melanoma, including metastatic melanoma in vivo. The present compounds exhibit enhanced uptake in cancerous cells and tissue and decreased renal uptake in kidney, evidencing favorable pharmacokinetics of compounds of the present invention. The compounds according to the present invention represent an advance in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention are also useful for initiating therapy for melanoma as well as monitor patients' response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

    COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME

    公开(公告)号:US20150239952A1

    公开(公告)日:2015-08-27

    申请号:US14629791

    申请日:2015-02-24

    申请人: STC.UNM

    发明人: Yubin Miao Haixun Guo

    IPC分类号: C07K14/68 A61K51/08

    摘要: The present invention is directed to novel non-invasive diagnostic tools/compounds to image cancers, especially, melanoma, including metastatic melanoma in vivo. The present compounds exhibit enhanced uptake in cancerous cells and tissue and decreased renal uptake in kidney, evidencing favorable pharmacokinetics of compounds of the present invention. The compounds according to the present invention represent an advance in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention are also useful for initiating therapy for melanoma as well as monitor patients' response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

    Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
    8.
    发明授权
    Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same 有权
    用于诊断和治疗黑素瘤的Arg-Gly-Asp-共轭α-黑素细胞刺激激素杂交肽,包括转移性黑素瘤及与其相关的方法

    公开(公告)号:US09005575B2

    公开(公告)日:2015-04-14

    申请号:US13321942

    申请日:2010-05-28

    摘要: The present invention is directed to novel non-invasive diagnostic and therapeutic tools/compounds comprising a hybride cyclic peptide which utilizes a cyclic peptide chelating group wherein the compound binds to a MSH receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers. The novel imaging probes are capable of detecting cancerous melanoma cells, as well as their metastatic spread in tissues. This represents a quantum step forward in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention will also be useful to initiate therapy for melanoma as well as monitor patients response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compound according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

    摘要翻译: 本发明涉及新颖的非侵入性诊断和治疗工具/化合物,其包含利用环肽螯合基团的杂环环肽,其中所述化合物结合MSH受体以成像和治疗癌症,特别是黑素瘤,包括转移性黑素瘤 体内。 本发明代表了目前依赖于组织活检以诊断这些癌症的本领域的明显进步。 新型成像探针能够检测癌细胞黑素瘤细胞,以及它们在组织中的转移扩散。 这代表了使用非侵入性分子成像技术在黑素瘤的诊断和治疗中包括转移性黑素瘤的量子进步。 本发明的新型探针也可用于启动黑素瘤的治疗以及监测患者对化疗治疗的反应和用于治疗黑素瘤/转移性黑色素瘤的其它干预或治疗。 根据本发明的化合物可以用作许多病症和疾病状态的诊断工具以及用于治疗这些病症和疾病状态的治疗剂。